Abstract
The universal susceptibility of the human race to measles, and the relatively high mortality from the disease under conditions of poverty and crowding, render it desirable to have available an efficient method of protection, that could be used whenever conditions render it desirable. Such a method has been worked out and found to be of value during the last few years. It consists of the administration of small doses of convalescent measles serum as soon as possible after exposure to a case of measles. The use of convalescent serum in the prophylaxis of measles was a logical sequel to the application of human convalescent serums in preventing and curing other infectious diseases for which the causative agents, as in measles, have not yet been definitely isolated and identified. Scarlet fever<sup>1</sup>and poliomyelitis<sup>2</sup>are additional examples of infections in which the serum of convalescents and of recovered patients has
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
